CYBN 250117 12.50C (CYBN250117C12500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CYBN250117C12500

Watchlist

0.30
-0.10-25.00%

15min DelayClose Dec 24 13:00 ET

0.30High0.30Low

Intraday

5D
Daily

News

Express News | Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including Cyb003 12-Month Efficacy Results
ReutersDec 10 07:30 ET
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
BusinesswireDec 10 07:30 ET
Facet Life Sciences Named Regulatory Partner for Cybin's Neuropsychiatry Therapeutics Development Pipeline
PR NewswireDec 4 14:00 ET
Cybin to Discuss Breakthrough Treatments at Fireside Chat
TipRanksDec 4 08:09 ET
Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024
BusinesswireDec 4 07:30 ET
Cybin Inc. Advances in Mental Health Treatments
TipRanksNov 25 22:58 ET

Comments

Jaguar8

Dec 10 06:44

NEWS

$Cybin (CYBN.US)$
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
Tuesday, 10th December at 7:30 am
- Poster presentations highlight clinical data across Cybin's CYB003 deuterated psilocin and DMT programs -
Cybin Inc. (NYSE: CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new...

Trytosaveabit

Dec 4 13:05

Update! Cybin gettin serious!

$Cybin (CYBN.US)$PR Newswire· 2 mins ago
PHOENIXVILLE, Pa., Dec. 4, 2024 /PRNewswire/ -- Facet Life Sciences, a leader in US regulatory strategy and product development solutions for the life sciences industry, has been named as the US regulatory partner for Cybin Inc. ("Cybin"), a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative treatment options to address the large unmet need for people ...

Mr Trecherous

Nov 25 20:06

Get Healthy 💪🏼 🥑 🥥 🍄 🐮

$Trump Media & Technology (DJT.US)$ $Pfizer (PFE.US)$ $McDonald's (MCD.US)$ $Tesla (TSLA.US)$ $AMC Entertainment (AMC.US)$ $Cybin (CYBN.US)$

Moo Humor

EZ_money

Nov 21 10:30

$Cybin (CYBN.US)$ buying more now 🖕

EZ_money

Nov 19 07:44

$Cybin (CYBN.US)$👀 more news out on trials 100% effectiveness so far on the therapy drug for treating depression
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$